BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31708480)

  • 1. Incidental diagnosis of neuroendocrine tumour with
    Morales MI; Erhard A; Lozano MD; Quincoces G; Richter JA; Rodríguez-Fraile M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):102-103. PubMed ID: 31708480
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Akdemir EN; Tuncel M; Akyol F; Bilen CY; Baydar DE; Karabulut E; Ozen H; Caglar M
    World J Urol; 2019 May; 37(5):813-821. PubMed ID: 30151600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor.
    Vamadevan S; Shetty D; Le K; Bui C; Mansberg R; Loh H
    Clin Nucl Med; 2016 Oct; 41(10):804-6. PubMed ID: 27454602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
    Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
    Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of metastatic disease on
    Yaxley JW; Raveenthiran S; Nouhaud FX; Samaratunga H; Yaxley WJ; Coughlin G; Yaxley AJ; Gianduzzo T; Kua B; McEwan L; Wong D
    BJU Int; 2019 Sep; 124(3):401-407. PubMed ID: 31141284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor.
    Luong TV; Iversen P; Bouchelouche K; Arveschoug AK
    Clin Nucl Med; 2020 May; 45(5):379-382. PubMed ID: 32149792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: A case report.
    Sampaio Vieira T; Borges Faria D; Souto Moura C; Francisco E; Barroso S; Pereira de Oliveira J
    Medicine (Baltimore); 2018 Sep; 97(36):e11878. PubMed ID: 30200073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
    Acar E; Kaya GÇ
    Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hamed MAG; Basha MAA; Ahmed H; Obaya AA; Afifi AHM; Abdelbary EH
    Acad Radiol; 2019 Apr; 26(4):450-460. PubMed ID: 29935970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental Detection of Pleomorphic Sarcoma on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer.
    Mathew B; Agrawal A; Purandare NC; Ramadwar M; Menon S; Bakshi G; Joshi A; Puranik A; Shah S; Rangarajan V
    Clin Nucl Med; 2020 Feb; 45(2):e120-e121. PubMed ID: 31490315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous cystadenoma mimicking cystic pancreatic neuroendocrine tumor on
    Passand GT; Marichez A; Debordeaux F; Pinaquy JB; Chiche L
    Diagn Interv Imaging; 2022 Nov; 103(11):563-565. PubMed ID: 36280584
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidental Detection of Hypothyroidism on 68Ga-PSMA-HBED-CC PET/CT Imaging.
    Sood A; Vadi SK; Kumar R; Singh H; Mittal BR
    Clin Nucl Med; 2020 Apr; 45(4):e217-e218. PubMed ID: 32108699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation.
    Chen S; Cheung SK; Wong KN; Wong KK; Ho CL
    Clin Nucl Med; 2016 Dec; 41(12):959-960. PubMed ID: 27764046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68 Ga-PSMA PET/CT in Hepatic Metastasis From Pancreatic Neuroendocrine Tumor.
    Chen S; Lin Z; Wang C; Miao W
    Clin Nucl Med; 2023 Nov; 48(11):991-993. PubMed ID: 37796174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of a
    Rousseau C; Le Thiec M; Ferrer L; Rusu D; Rauscher A; Maucherat B; Frindel M; Baumgartner P; Fleury V; Denis A; Morel A; Varmenot N; Debeaupuis E; Campion L; Kraeber-Bodéré F
    Prostate; 2019 Sep; 79(13):1514-1522. PubMed ID: 31421657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection Efficacy of Hybrid
    Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT.
    Usmani S; Ahmed N; Marafi F; Rasheed R; Amanguno HG; Al Kandari F
    Clin Nucl Med; 2017 May; 42(5):410-413. PubMed ID: 28240661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT.
    Bilgin R; Ergül N; Çermik TF
    Clin Nucl Med; 2016 Dec; 41(12):956-958. PubMed ID: 27824323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor.
    Ji X; Dong A; He Q; Dong H; Zuo C
    Clin Nucl Med; 2020 May; 45(5):e245-e248. PubMed ID: 32049733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.